D-498-2013 Class III Terminated

Recalled by Aurobindo Pharma USA Inc — Plainsboro, NJ

FDA drug recall D-498-2013 was initiated by Aurobindo Pharma USA Inc on Apr 9, 2013 and is designated Class III. Reason for recall: Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label The recall status is terminated (terminated Jan 23, 2014). Affected quantity: 1776 bottles.

Recall details

Product Type
Drugs
Report Date
Jun 5, 2013
Initiation Date
Apr 9, 2013
Termination Date
Jan 23, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1776 bottles

Product description

Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobindo Pharma USA Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad- 500 072 India

Reason for recall

Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label

Distribution pattern

Nationwide

Code information

Lot KP3012001-A Exp.12/13 Lot KP3012002-A Exp.12/13

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-498-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-498-2013. Report a data issue: hello@regdatalab.com.